tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Pharma Mar SA Reports Strong H1 2025 Performance
Company AnnouncementsPharma Mar SA Reports Strong H1 2025 Performance
4d ago
Pharma Mar Concludes Share Buy-back Program Early
PremiumCompany Announcements
Pharma Mar Concludes Share Buy-back Program Early
2M ago
Pharma Mar SA Announces Dividend Payment for 2025
PremiumCompany Announcements
Pharma Mar SA Announces Dividend Payment for 2025
2M ago
Pharma Mar S.A. Shareholders Approve Board Proposals
PremiumCompany Announcements
Pharma Mar S.A. Shareholders Approve Board Proposals
2M ago
Pharma Mar’s Strategic Shareholder Meeting
PremiumCompany Announcements
Pharma Mar’s Strategic Shareholder Meeting
2M ago
Pharma Mar’s Zepzelca® Shows Promising Results in Lung Cancer Treatment
PremiumCompany AnnouncementsPharma Mar’s Zepzelca® Shows Promising Results in Lung Cancer Treatment
2M ago
Pharma Mar SA Reports on Recent Share Buy-Back Activities
Premium
Company Announcements
Pharma Mar SA Reports on Recent Share Buy-Back Activities
2M ago
PharmaMar Seeks EMA Approval for New Lung Cancer Treatment
Premium
Company Announcements
PharmaMar Seeks EMA Approval for New Lung Cancer Treatment
3M ago
Pharma Mar SA Updates on Share Buy-Back Program
PremiumCompany Announcements
Pharma Mar SA Updates on Share Buy-Back Program
3M ago
Pharma Mar Gains Approval for Cancer Drug in Argentina
PremiumCompany Announcements
Pharma Mar Gains Approval for Cancer Drug in Argentina
3M ago
Pharma Mar’s Zepzelca® Gains Approval in Argentina for SCLC Treatment
PremiumCompany Announcements
Pharma Mar’s Zepzelca® Gains Approval in Argentina for SCLC Treatment
3M ago
Pharma Mar S.A. Announces 2025 Shareholders’ Meeting with Key Agenda Items
PremiumCompany Announcements
Pharma Mar S.A. Announces 2025 Shareholders’ Meeting with Key Agenda Items
3M ago
Pharma Mar SA Reports Strong Q1 2025 Revenue Growth
PremiumCompany AnnouncementsPharma Mar SA Reports Strong Q1 2025 Revenue Growth
3M ago
PharmaMar Reports Strong Q1 2025 Financial Growth
Premium
Company Announcements
PharmaMar Reports Strong Q1 2025 Financial Growth
4M ago
Pharma Mar Announces 2025 Shareholders Meeting with Key Governance Proposals
Premium
Company Announcements
Pharma Mar Announces 2025 Shareholders Meeting with Key Governance Proposals
4M ago
Is PHMMF a Buy, Before Earnings?
PremiumPre-Earnings
Is PHMMF a Buy, Before Earnings?
4M ago
Pharma Mar SA Reports on Recent Share Buy-Back Activities
PremiumCompany Announcements
Pharma Mar SA Reports on Recent Share Buy-Back Activities
4M ago
Pharma Mar Adjusts Financial Strategy with New Share Buyback Program
PremiumCompany Announcements
Pharma Mar Adjusts Financial Strategy with New Share Buyback Program
4M ago
Pharma Mar’s Credit Rating Maintained at ‘BB+’
PremiumCompany Announcements
Pharma Mar’s Credit Rating Maintained at ‘BB+’
4M ago
Pharma Mar Partners with Merck for Japanese Launch of Cancer Drug
PremiumCompany AnnouncementsPharma Mar Partners with Merck for Japanese Launch of Cancer Drug
4M ago
Pharma Mar Implements Share Delivery Plan to Boost Employee Engagement
Premium
Company Announcements
Pharma Mar Implements Share Delivery Plan to Boost Employee Engagement
4M ago
Sylentis Secures 21.1 Million Euro Grant for RNA Drug Production
Premium
Company Announcements
Sylentis Secures 21.1 Million Euro Grant for RNA Drug Production
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >